253 related articles for article (PubMed ID: 28238295)
1. Use of intranasal corticosteroids in adenotonsillar hypertrophy.
Sakarya EU; Bayar Muluk N; Sakalar EG; Senturk M; Aricigil M; Bafaqeeh SA; Cingi C
J Laryngol Otol; 2017 May; 131(5):384-390. PubMed ID: 28238295
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea.
Kheirandish-Gozal L; Serpero LD; Dayyat E; Kim J; Goldman JL; Snow A; Bhattacharjee R; Gozal D
Eur Respir J; 2009 May; 33(5):1077-84. PubMed ID: 19047310
[TBL] [Abstract][Full Text] [Related]
3. Double-blind placebo-controlled randomized clinical trial on the efficacy of Aerosal in the treatment of sub-obstructive adenotonsillar hypertrophy and related diseases.
Gelardi M; Iannuzzi L; Greco Miani A; Cazzaniga S; Naldi L; De Luca C; Quaranta N
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1818-24. PubMed ID: 24041858
[TBL] [Abstract][Full Text] [Related]
4. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy.
Zhang L; Mendoza-Sassi RA; César JA; Chadha NK
Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD006286. PubMed ID: 18646145
[TBL] [Abstract][Full Text] [Related]
5. Atopy does not affect the frequency of adenotonsillar hypertrophy and sleep apnoea in children who snore.
Alexopoulos EI; Bizakis J; Gourgoulianis K; Kaditis AG
Acta Paediatr; 2014 Dec; 103(12):1239-43. PubMed ID: 25130904
[TBL] [Abstract][Full Text] [Related]
6. [Otolaryngologist's perspective in childhood adenotonsillar hypertrophy].
Ye JY; Li JJ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 30(6):449-451. PubMed ID: 29871036
[TBL] [Abstract][Full Text] [Related]
7. Antileukotrienes in adenotonsillar hypertrophy: a review of the literature.
Kar M; Altıntoprak N; Muluk NB; Ulusoy S; Bafaqeeh SA; Cingi C
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4111-4117. PubMed ID: 26980339
[TBL] [Abstract][Full Text] [Related]
8. Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone.
Criscuoli G; D'Amora S; Ripa G; Cinquegrana G; Mansi N; Impagliazzo N; Pisacane A
Pediatrics; 2003 Mar; 111(3):e236-8. PubMed ID: 12612277
[TBL] [Abstract][Full Text] [Related]
9. Can adenoidal hypertrophy be treated with intranasal steroids?
Berlucchi M; Sessa M
Rev Recent Clin Trials; 2010 May; 5(2):123-7. PubMed ID: 20199384
[TBL] [Abstract][Full Text] [Related]
10. Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation.
Scadding G
Pediatr Allergy Immunol; 2010 Dec; 21(8):1095-106. PubMed ID: 20609137
[TBL] [Abstract][Full Text] [Related]
11. Effects of body mass index and adenotonsillar size on snoring sound intensity levels at highest power.
Seren E; San T; Cingi C; Muluk NB; Durukan K
Int J Pediatr Otorhinolaryngol; 2014 Jan; 78(1):50-4. PubMed ID: 24268721
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children.
Chohan A; Lal A; Chohan K; Chakravarti A; Gomber S
Int J Pediatr Otorhinolaryngol; 2015 Oct; 79(10):1599-608. PubMed ID: 26235732
[TBL] [Abstract][Full Text] [Related]
13. Adenotonsillar hypertrophy and upper airway obstruction in evolutionary perspective.
Grundfast KM; Wittich DJ
Laryngoscope; 1982 Jun; 92(6 Pt 1):650-6. PubMed ID: 7087627
[TBL] [Abstract][Full Text] [Related]
14. Physical and emotional disturbances in children with adenotonsillar hypertrophy.
Kurnatowski P; Putyński L; Łapienis M; Kowalska B
J Laryngol Otol; 2008 Sep; 122(9):931-5. PubMed ID: 18047762
[TBL] [Abstract][Full Text] [Related]
15. The relation between childhood obesity and adenotonsillar hypertrophy.
Daar G; Sarı K; Gencer ZK; Ede H; Aydın R; Saydam L
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):505-9. PubMed ID: 25876003
[TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnea in children: relative contributions of body mass index and adenotonsillar hypertrophy.
Dayyat E; Kheirandish-Gozal L; Sans Capdevila O; Maarafeya MMA; Gozal D
Chest; 2009 Jul; 136(1):137-144. PubMed ID: 19225059
[TBL] [Abstract][Full Text] [Related]
17. Oxidants and antioxidants in tonsillar and adenoidal tissue in chronic adenotonsillitis and adenotonsillar hypertrophy in children.
Kiroglu AF; Noyan T; Oger M; Kara T
Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):35-8. PubMed ID: 15961164
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of the medical treatment of adenoid hypertrophy in children with house dust mite allergy].
Modrzyński M; Zawisza E; Rapiejko P; Przybylski G; Lipiec A; Królikiewicz J
Przegl Lek; 2003; 60(10):633-6. PubMed ID: 15052722
[TBL] [Abstract][Full Text] [Related]
19. Obstructive sleep apnoea in children with adenotonsillar hypertrophy: prospective study.
Li AM; Hui S; Wong E; Cheung A; Fok TF
Hong Kong Med J; 2001 Sep; 7(3):236-40. PubMed ID: 11590263
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of adenotonsillar size for prediction of severity of obstructive sleep apnea and flow limitation.
Hwang SH; Guilleminault C; Park CS; Kim TW; Hong SC
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):326-34. PubMed ID: 23715686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
